Geron Corp (NASDAQ: GERN) kicked off on Friday, down -0.83% from the previous trading day, before settling in for the closing price of $3.60. Over the past 52 weeks, GERN has traded in a range of $1.64-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 72.04% over the last five years. While this was happening, its average annual earnings per share was recorded 18.76%. With a float of $564.66 million, this company’s outstanding shares have now reached $603.10 million.
The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is 96.53%, operating margin of -705.46%, and the pretax margin is -682.48%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 6.59%, while institutional ownership is 78.45%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 2.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 72.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Analysing the last 5-days average volume posted by the [Geron Corp, GERN], we can find that recorded value of 20.19 million was better than the volume posted last year of 14.56 million. As of the previous 9 days, the stock’s Stochastic %D was 62.00%. Additionally, its Average True Range was 0.16.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 22.77%, which indicates a significant decrease from 46.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.45% in the past 14 days, which was lower than the 42.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.91, while its 200-day Moving Average is $4.11. Now, the first resistance to watch is $3.65. This is followed by the second major resistance level at $3.74. The third major resistance level sits at $3.79. If the price goes on to break the first support level at $3.51, it is likely to go to the next support level at $3.46. Now, if the price goes above the second support level, the third support stands at $3.37.
Geron Corp (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 2.14 billion has total of 604,501K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -184,130 K annual income. Company’s last quarter sales were recorded 28,270 K and last quarter income was -26,450 K.
